IXC 2.63% 7.8¢ invex therapeutics ltd

“The point being, fundamentals have improved drastically, but...

  1. 17,464 Posts.
    lightbulb Created with Sketch. 416
    “The point being, fundamentals have improved drastically, but IXC is being weighed down by macro conditions of the wider biotech industry, alongside wider macro conditions again of bordering on a global wide recession. “

    surely that goes to the importance of TA then
    As I said a day can be a long time in the market 2.5 years is an age !

    I agree though the company needs to step up and keep the pot simmering or boil it and tell us about more potential etc etc increasing the FA
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.8¢
Change
0.002(2.63%)
Mkt cap ! $5.862M
Open High Low Value Volume
7.8¢ 7.8¢ 7.8¢ $16 210

Buyers (Bids)

No. Vol. Price($)
1 68219 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 16290 1
View Market Depth
Last trade - 13.15pm 05/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.